2017 annual financial data
Corcept Therapeutics 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was 38.28%.
Operating income was 52,855,000 USD and net income was 129,122,000 USD.
Operating cash flow was 60,935,000 USD.
Get free Corcept Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 159,201,000 USD
- Operating income
- 52,855,000 USD
- Net income
- 129,122,000 USD
- Operating cash flow
- 60,935,000 USD